Ashley Mays, MD
Cardiovascular Disease · Missoula, MTNPI 1861548471
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,004 of the $4,352 with a category attached, or 69.0%. Abbott accounts for 88.7% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $2,534, more than ten times the $37 reported in 2021.
Across 44 payments — averaging $98.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Boston Scientific$222
- Medtronic$197
- Abiomed$37
- Philips North America LLC$22
- Angiodynamics, Inc.$15
What the payments were for
- Travel & lodging$3,00469%
- Food & beverage$1,34831%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 33 | $3,860 |
| Boston Scientific | 5 | $222 |
| Medtronic | 3 | $197 |
| Abiomed | 1 | $37 |
| Philips North America LLC | 1 | $22 |
| Angiodynamics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRICLIP$2,078
- MitraClip$945
- COREVALVE EVOLUT R$164
- WATCHMAN FLX$130
How this compares
$4,352 in reported general payments places this provider in the 70th percentile of 49 cardiovascular disease providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 152 | $200,364 |
| Repatha SureclickEvolocumab | 62 | $62,549 |
| XareltoRivaroxaban | 44 | $46,317 |
| JardianceEmpagliflozin | 37 | $43,352 |
| EntrestoSacubitril/Valsartan | 17 | $23,608 |
| Metoprolol Succinate | 298 | $6,869 |
| Potassium Chloride | 88 | $2,996 |
| Atorvastatin Calcium | 183 | $2,433 |
| Losartan Potassium | 139 | $1,878 |
| Lisinopril | 155 | $1,877 |
| Torsemide | 72 | $1,676 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 61 | $1,537 |
| Ezetimibe | 49 | $1,044 |
| Rosuvastatin Calcium | 67 | $1,016 |
| Carvedilol | 75 | $927 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Missoula
- Jocelyn SpoonMissoula$17K
- Patricia KellyMissoula$12K
- Newton CoutinhoMissoula$10K
- Michael ReedMissoula$8K
- Gregory WoodMissoula$6K
- Morgan KelloggMissoula$4K
- Matthew WeissMissoula$3K
- Puneet BansalMissoula$2K
- Alexander JehleMissoula$2K
- Jon McGregorMissoula$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.